Alisporivir Completed Phase 1 Trials for Hepatic Insufficiency / Mild and Moderate Hepatic Impairment

IndicationsStatusPurposePhase
CompletedNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT01860326Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects